E. COLI BACTERIOPHAGE ESC-COP-14 AND USE THEREOF IN INHIBITING GROWTH OF PATHOGENIC E. COLI

Number of patents in Portfolio can not be more than 2000

United States of America Patent

APP PUB NO 20210283202A1
SERIAL NO

17258722

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention relates to a Myoviridae bacteriophage Esc-COP-14 (Accession number: KCTC 13528BP) isolated from nature, and characterized by having the ability to specifically kill Escherichia coli and having the genome represented by SEQ. ID. NO: 1, and to a method for preventing and treating the infection of pathogenic Escherichia coli using the composition comprising Myoviridae bacteriophage Esc-COP-14 as an active ingredient.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
INTRON BIOTECHNOLOGY INCSANGDAEWON-DONG #701-704 JUNGANG INDUSPIA 137 SAGIMAKGOL-RO JUNGWON-GU SEONGNAM-SI GYEONGGI-DO 13202

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Jun, Soo Youn Seoul, KR 60 76
Kang, Sang Hyeon Seoul, KR 64 100
Lee, Hyun Joo Seoul, KR 93 634
Paik, Hyoung Rok Incheon, KR 12 8
Son, Jee Soo Seoul, KR 31 57
Yoon, Seong Jun Seoul, KR 66 92

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation